We thank Dr. P. Seth for providing AVCMVp53 and Dr. B. Massie for providing AVCMVlacZ. This work was supported by the Medical Research Council of Canada and Cancer Research Society Inc. J.N. is a senior research scholar of Fonds de la Recherche en Santé du Québec (FRSQ).

  • 1
    Acsadi G., Jani A., Massie B., Simoneau M., Holland P., Blaschuk K., Karpati G. (1994) A differential efficiency of adenovirusmediated in vivo gene transfer into skeletal muscle cells of different maturity.Hum. Mol. Genet. 3,579584.
  • 2
    Baker S.J. & Reddy E.P. (1996) Transducers of life and death : TNF receptor superfamily and associated proteins.Oncogene 12,19.
  • 3
    Beg A.A. & Baltimore D. (1996) An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274,782784.
  • 4
    Beidler D.R., Tewari M., Friesen P.D., Poirier G., Dixit V.M. (1995) The baculovirus p35 protein inhibits Fas- and tumor necrosis factor-induced apoptosis.J. Biol. Chem. 270,1652616528.
  • 5
    Calles C., Helmberg A., Karin M. (1994) p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes.Nature 370,220223.
  • 6
    Chen L., Maréchal V., Moreau J., Levine A.J., Chen J. (1997) Proteolytic cleavage of the mdm2 oncoprotein during apoptosis.J. Biol. Chem. 272,2296622973.
  • 7
    D'Souza S., Alinaukas K., McCrae E., Goodyer C., Antel J.P. (1995) Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury.J. Neurosci. 15,72937300.
  • 8
    D'Souza S.D., Bonetti B., Balasingam V., Cashman N.R., Barker P.A., Troutt A.B., Raine C.S., Antel J.P. (1996) Multiple sclerosis : fas signalling in oligodendrocyte cell death.J. Exp. Med. 184,23612370.
  • 9
    Eizenberg O., Faber-Elman A., Gottlieb E., Oren M., Rotter V., Schwartz M. (1995) Direct involvement of p53 in programmed cell death of oligodendrocytes.EMBO J. 14,11361144.
  • 10
    Erhardt P., Tomaselli K.J., Cooper G.M. (1997) Identification of the mdm2 oncoprotein as a substrate for CPP32-like apoptotic proteases.J. Biol. Chem. 272,1504915052.
  • 11
    Friedlander P., Haupt Y., Prives C., Oren M. (1996) A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis.Mol. Cell. Biol. 16,49614971.
  • 12
    Fuchs S.Y., Adler V., Pincus M.R., Ronai Z. (1998) MEKK1/JNK signaling stabilizes and activates p53.Proc. Natl. Acad. Sci. USA 95,1054110546.
  • 13
    Gottlieb W.H., Watson J.M., Rezai A., Johnson M., Martinez-Maza O., Berek J.S. (1994) Cytokine-induced modulation of tumor suppressor gene expression in ovarian cancer cells : up-regulation of p53 gene expression and induction of apoptosis by tumor necrosis factor-alpha.Am. J. Obstet. Gynecol. 170,11211130.
  • 14
    Harris C.C. (1996) Structure and function of the p53 tumor suppressor gene : clues for rational cancer therapeutic strategies.J. Natl. Cancer Inst. 88,14421455.
  • 15
    Haupt Y., Rowan S., Shaulian E., Vousden K.H., Oren M. (1995) Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev. 9,21702183.
  • 16
    Hecker D., Page G., Lohrum M., Weiland S., Scheidtmann K.H. (1996) Complex regulation of the DNA-binding activity of p53 by phosphorylation : differential effects of individual phosphorylation sites on the interaction with different binding motifs.Oncogene 12,953961.
  • 17
    Hu M.C.T., Qiu W.R., Wang Y.P. (1997) JNK1, JNK2 and JNK3 are p53 N-terminal serine 34 kinases.Oncogene 15,22772287.
  • 18
    Jaattela M., Benedict M., Tewari M., Shayman J.A., Dixit V.M. (1995) Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells.Oncogene 10,22972305.
  • 19
    Kayatose D., Gudas J., Nguyen H., Srivastava S., Cowan K., Seth P. (1995) Cytotoxic effects of adenovirus-mediated wild type p53 protein expression in normal and tumor mammary epithelial cells.Clin. Cancer Res. 1,889897.
  • 20
    Ladiwala U., Lachance C., Simoneau S.J., Bhakar A., Barker P.A., Antel J.P. (1998) p75 neurotrophin receptor expression on adult human oligodendrocytes : signaling without death in response to NGF.J. Neurosci. 18,12971304.
  • 21
    Levine A.J. (1997) p53, the cellular gatekeeper for growth and division.Cell 88,323331.
  • 22
    Li Y., Chopp M., Zhang Z.G., Zaloga C., Niewenhuis L., Gautam S. (1994) p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats.Stroke 25,849855.
  • 23
    Liu Z., Hsu H., Goeddel D.V., Karin M. (1996) Dissection of TNF receptor 1 effector functions : JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87,565576.
  • 24
    Lochmüller H., Jani A., Huard J., Prescott S., Simoneau M., Massie B., Karpati G., Acsadi G. (1994) Emergence of early region 1 (E1)-containing replication competent adenovirus in stocks of replication defective adenovirus recombinants (▵E1 + ▵E3) during multiple passages in 293 cells. Hum. Gene Ther. 5,14851491.
  • 25
    Ludwig R.L., Bates S., Vousden K.H. (1996) Differential activation of target cellular promoters by p53 mutants impairs apoptotic function.Mol. Cell. Biol. 16,49524960.
  • 26
    Mayr G.A., Reed M., Wang P., Wang Y., Schwedes J.F., Tegtmeyer P. (1995) Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.Cancer Res. 55,24102417.
  • 27
    Milne D.W., Campbell L.E., Campbell D.G., Meek D.W. (1995) p53 phosphorylation in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-jun kinase, JNK1.J. Biol. Chem. 270,55115518.
  • 28
    Miyashita T. & Reed J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.Cell 80,293299.
  • 29
    Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Lieberman D.A., Hoffman B., Reed J.C. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.Oncogene 9,17991805.
  • 30
    Nagata S. (1997) Apoptosis by death factor.Cell 88,355356.
  • 31
    Owen-Schaub L.B., Zhang W., Cusack J.C., Angelo L.S., Santee S.M., Fujiwara T., Roth J.A., Deisseroth A.B., Zhang W.W., Kruzel E., Radinsky R. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/Apo-1 expression.Mol. Cell. Biol. 15,30323040.
  • 32
    Ozawa K., Suchanek G., Breitschopf H., Bruck W., Budka H., Jellinger K., Lassmann H. (1994) Patterns of oligodendroglia pathology in multiple sclerosis.Brain 117,13111322.
  • 33
    Piette J., Neel H., Maréchal V. (1997) Mdm2 : keeping p53 under control.Oncogene 15,10011010.
  • 34
    Probert L., Akassoglou K., Pasparakis M., Kontogeorgos G., Kollias K. (1995) Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumour necrosis factor alpha.Proc. Natl. Acad. Sci. USA 92,1129411298.
  • 35
    Raine C.S. (1990) Demyelinating disease, inTextbook of Neuropathology (Davis R. L. and Robertson D. M., eds), pp. 535620. Williams & Wilkins, Baltimore.
  • 36
    Sakhi S., Bruce A., Sun N., Tocco G., Baudry M., Schreiber S.S. (1997) Induction of tumor suppressor p53 and DNA fragmentation in organotypic hippocampal cultures following excitotoxin treatment.Exp. Neurol. 145,8188.
  • 37
    Selmaj K.W., Raine C.S., Canella B., Brosnan C. (1991) Identification of lymphotoxin and tumour necrosis factor in multiple sclerosis lesions.J. Clin. Invest. 87,949954.
  • 38
    Seto E., Usheva A., Zambetti G.P., Momand J., Horikoshi N., Weinmann R., Levine A.J., Shenk T. (1992) Wild-type p53 binds to the TATA-binding protein and represses transcription.Proc. Natl. Acad. Sci. USA 89,1202812032.
  • 39
    Tamura T., Aoyama N., Saya H., Haga H., Futami S., Miyamoto M., Koh T., Ariyasu T., Tachi M., Kasuga M., Takahashi R. (1995) Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.Oncogene 11,19391946.
  • 40
    Taupin V., Renno T., Bourbonnière L., Peterson A.C., Rodriguez M., Owens T. (1997) Increased severity of experimental autoimmune encephalitis, chronic macrophage/microglial reactivity, and demyelination in transgenic mice producing tumor necrosis factor-α in the central nervous system.Eur. J. Immunol. 27,905913.
  • 41
    Yong V.W. & Antel J.P. (1992) Culture of glial cells from human biopsies, inProtocols for Neural Cell Culture (Richardson A. and Federoff S., eds), pp. 8186. Humana Press, St. Louis.
  • 42
    Zhang P., Miller B.S., Rosenzweig S.A., Bhat N.R. (1996) Activation of c-jun N-terminal kinase/stress-activated protein kinase in primary glial cultures.J. Neurosci. Res. 46,114121.